胞嘧啶脱氨酶尿嘧啶-磷酸核糖基转移酶融合基因/5-氟胞嘧啶治疗鼻咽癌的实验研究  

Experimental study of treating nasopharyngeal carcinoma with fusion cytosine deaminase-uracil phosphoribosyltransferase suicide gene and 5-Flurocytosine

在线阅读下载全文

作  者:唐瑶云[1] 钟宇[1] 赵素萍[1] 肖健云[1] 

机构地区:[1]中南大学湘雅医院耳鼻咽喉科,湖南长沙410008

出  处:《中国耳鼻咽喉头颈外科》2006年第11期766-770,共5页Chinese Archives of Otolaryngology-Head and Neck Surgery

基  金:国家自然科学基金(30300414)

摘  要:目的研究胞嘧啶脱氨酶-尿嘧啶磷酸核糖基转移酶融合基因/5-氟胞嘧啶(fusion cytosine deaminaseuracil phosphoribosyl transferase gene/5-Flurocy-tosine,FCU/5-FC)对鼻咽癌CNE-2细胞的杀伤效应以及对鼻咽癌移植瘤生长的抑制作用。方法构建表达质粒载体pcDNA3.1(-)CMVe·Egr-1·FCU,BamH Ⅰ酶切鉴定重组质粒,分析FCU基因和融合启动子CMVe·Egr-1的序列。电穿孔法将重组质粒转染CNE-2细胞,300μg/ml-600μg/mlG418筛选14天获得稳定表达FCU基因的CNE-2细胞,RT—PCR鉴定FCU基因的表达。以转染空白载体pcDNA3.1(-)的CNE-2细胞为对照,MTT法观察5-FC对表达FCU基因的CNE-2细胞生长的抑制作用,考察FCU基因的细胞旁杀效应。5×10^6的CNE-2细胞接种裸鼠右腋下,建立鼻咽癌裸鼠移植瘤模型,12天后将裸鼠随机分成3组:CU组,CU+PBS组和CU+5-FC组,观察不同处理对移植瘤生长的抑制作用。结果酶切和序列分析证明重组质粒含完整的FCU基因和Egr-1启动子的核心序列,RT-PCR从转染细胞总RNA中扩出330bp的预期片段。表达FCU基因的CNE-2细胞在5-FC干预下,生长受到抑制。随着表达FCU基因的细胞比例增加,细胞存活率相应地下降。CU组,CU+PBS组移植瘤体积与CU+5-FC组有显著性差异(P〈0.05)。结论表达FCU基因的CNE-2细胞可以被5-FC杀伤,FCU/5-FC系统抑制了移植瘤生长,为治疗鼻咽癌提供了新的策略。OBJECTIVE To study the killing effect of fusion cytosine deaminase-uracil- phosphoribosyltransferase gene /5-Flurocytosine (FCU/5-FC) on the nasopharyngeal carcinoma cell line CNE-2 cells in vitro and the antitumour activity was also observed in situ. METHODS Constructed plasmid pcDNA3.1(-)CMVe.Egr-1.FCU was verified by enzyme digestion of BamH Ⅰ and automatic sequence analysis, then it was introduced into CNE-2 cells by electroperforation to yield cells expressing of FCU stably after selecting with G418(300μg/ml) for 14 days. The expression of FCU mRNA in transfected CNE-2 cells was tested by RT-PCR. Compared with CNE-2 cells transferred with pcDNA3.1(-), in vitro chemosensitivity of FCU expressing CNE-2 cells to 5-FC was detected by MTT assay. Furthermore, bystander effect of FCU was analyzed by MTT assay. At last NPC model was employed by inoculating CNE-2 cells in the right flank of nude mice and after 12 days of inoculation, those rats were randomly divided into three groups(n=8): CU group, CU+PBS group, CU+5-FC group. The suppression of NPC growth in model was observed after giving different treatments. RESULTS The recombinant plasmid contained full-length coding region sequence of FCU gene and core sequence of Egr-1 promoter. A anticipated 330bp fragment was amplified from total RNA of FCU-expressing CNE-2 cells by RT-PCR. In vitro study, FCU-positive CNE-2 cells were killed by 5-FC while FCU-untransferred CNE-2 cells was killed undistinctively, and the relative survival rates of two groups had significant difference(P〈0.01), moreover a powerful bystander effect of FCU in killing CNE-2 cells was approved. In situ study, the tumor volume of CU+5-FC group was different with that of CU group or CU+PBS group, but no significant difference existed between CU group and CU+PBS group(P〉0.05). CONCLUSION FCU-expressing CNE-2 cells can be killed in presence of 5-FC, and the xerografts of NPC were inhibited by FCU/5-FC system, which made of the system a candidate for tre

关 键 词:胞嘧啶脱氨酶 尿嘧啶 糖基转移酶 基因疗法 鼻咽肿瘤 

分 类 号:R739.63[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象